Navigation Links
Biodel Reports Second Quarter Fiscal Year 2011 Financial Results
Date:5/5/2011

DANBURY, Conn., May 5, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported financial results for the quarter ended March 31, 2011.

Second Quarter Fiscal Year 2011 Financial Results

Biodel reported a net loss for the three months ended March 31, 2011 of $5.4 million, or $0.21 per share, compared to a net loss of $10.4 million, or $0.44 per share, for the same period in the prior year.

Research and development expenses were $2.9 million for the three months ended March 31, 2011, compared to $7.0 million for the same period in the prior year.  The decrease of $4.1 million in expenses was primarily attributed to non-recurring events that occurred in the previous fiscal year including the conclusion of the Linjeta™ Phase 3 extension trials in February 2010 at a cost of $2.1 million; recombinant human insulin purchased at a cost of $1 million; professional fees of $0.7 million related to the 120 day safety report filing of Linjeta™ and follow-on questions from the FDA, and pen development costs of $0.4 million.

General and administrative expenses totaled $2.3 million for the three months ended March 31, 2011, compared to $3.4 million for the same period in the prior year.  The decrease in general and administrative expenses was attributable to a decrease in personnel costs of $0.7 million as a result of lower headcount from 2010, and savings of $0.4 million in professional fees due to cost cutting measures.

Expenses for the three months ended March 31, 2011 and 2010 included $2.6 million in stock-based compensation expense related to options granted to employees and non-employee directors.  

Biodel did not recognize any revenue during the three months ended March 31, 2011 or 2010.

At March 31, 2011, Biodel had cash and cash equivalents of $17.6 million and 26.5 million shares outstanding.  


'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biodel to Report Second Quarter Fiscal Year 2011 Financial Results on May 5, 2011
2. BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
3. Biodel Announces Appointment of Dr. Brian J.G. Pereira as Board Chairman; Dr. Charles A. Sanders to Remain on Board
4. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
5. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
6. Biodel Inc. to Present at the Roth 23rd Annual OC Growth Stock Conference on March 16, 2011
7. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
8. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
9. Biodel Reports First Quarter Fiscal Year 2011 Financial Results
10. Biodel to Report First Quarter Fiscal Year 2011 Financial Results on February 3, 2011
11. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... BURLINGTON, Mass. , Sept. 23, 2014 ... in pricing and reimbursement (P&R) decision criteria ... along with expert insights into each country, ... messaging across different markets.  Global market access ... very specific market access requirements and challenges—and ...
(Date:9/23/2014)... 2014 Research and Markets ... Office Laboratory Markets, 3rd Edition" report to ... Office Laboratory Markets is Kalorama,s complete review of ... office laboratories are diverse in their capabilities and ... pregnancy and glucose tests. Some specialty practices and ...
(Date:9/23/2014)... HARRISBURG, Pa. , Sept. 23, 2014 ... prescription drugs Sat., Sept. 27, as part of National ... anonymous, no questions asked. Take-Back Day is ... Drug Enforcement Administration (DEA), aimed at encouraging the public ... that are prone to abuse and theft. ...
Breaking Medicine Technology:Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3
... WCRX ) today announced that it will issue its fourth ... opening on Friday, February 25, 2011. In addition ... call for all interested parties on Friday, February 25, 2011 at ... the call, please dial (877) 354 - 4056 in the United ...
... Management Association (PCMA) President and CEO Mark Merritt ... proposal which includes a provision encouraging TRICARE members to ... "The Pentagon,s budget proposal for the TRICARE ... mail-service pharmacies reduces costs and enhances access to prescription ...
Cached Medicine Technology:
(Date:9/23/2014)... of published studies found that FDG-PET technology is ... disease in regions where infections like histoplasmosis or ... suspicious for cancer could lead to unnecessary tests ... and mortality. , Histoplasmosis and other fungal ... concentrated in bird droppings and are found in ...
(Date:9/23/2014)... 23, 2014 World of Home Fitness ... support. Most recently, the gym has been raising money ... program. Throughout the year, World of Home Fitness has ... causes. , Over the summer, World of Home Fitness ... their Ageless Fitness program, participants helped feed seniors "one ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 As a ... before making a purchase. It’s difficult to trust testimonials ... easy for them to manipulate their customers into saying ... dilemma, but they tend to lack in depth coverage ... Reports was founded to fix this issue and ...
(Date:9/23/2014)... Karen Pallarito HealthDay Reporter ... if doctors and hospitals got paid for providing better ... better data for making informed health choices. A ... is headed. The report, from the IMS Institute for ... -- recent events expected to alter the delivery of health ...
(Date:9/23/2014)... rapidly developing, bringing with its advances promises of ... and treatment interventions. Genetic tests are already ... and hepatitis c virus (HPC), and emerging research ... screen for an individual,s susceptibility to addiction to ... , While there appear to be many benefits ...
Breaking Medicine News(10 mins):Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:World of Home Fitness Supports Meals on Wheels 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2
... is available in French . , OTTAWA ... satellite images, and other location-based or geospatial information and ... most pressing challenges, including public health. Through GeoConnections, Canadas ... merger of geomatics with public health because of the ...
... Pa., Sept. 17 Governor Edward G.,Rendell has appointed ... how Pennsylvanians with chronic disease receive health care in ... for,Pennsylvania health care reform plan. "About 78 percent ... 20 percent of all patients -- those with chronic ...
... SAN DIEGO, Sept. 17 CryoCor, Inc. (Nasdaq:,CRYO), a ... announced today that Edward F. Brennan, President and Chief,Executive ... to present at the Maxim Group First Annual Growth ... at 10:00 a.m. ET at The Grand,Hyatt Hotel. ...
... Sept. 17 John Brooke, General Manager of,Billian,s ... speaking at Dreamforce ,07 Global Gathering, Salesforce.com,s 5th,Annual ... week. Dreamforce is the ultimate gathering of ... base of Salesforce and AppExchance,users spanning industries, roles ...
... measure for pain screening may only be modestly accurate, according ... the University of North Carolina. In a study that appears ... Medicine, they evaluate the usefulness of a scale that asks ... 0 (no pain) to 10 (worst pain). , ...
... Nations General Assembly Tomorrow, September ... 18th, ... and governments failing to meet their millennium,commitment to halve hunger by 2015, the ... a,central role "on the table" of the 62nd United Nations General Assembly,Meetings. ...
Cached Medicine News:Health News:Canada's government funds $1.6M in modern geography to support public health decisions 2Health News:Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA 2Health News:Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA 3Health News:Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA 4Health News:Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA 5Health News:CryoCor to Present at Maxim Group First Annual Growth Conference in New York 2Health News:Billian's HealthDATA GM Speaking on Dreamforce 07 Panel 2Health News:Rating your pain from 0 to 10 might not help your doctor 2Health News:HungerFREE Campaign Tells UN: 'Put food on the table' 2
... Screen ELISA test system is a qualitative screening ... human sera. When performed according to the directional ... all ANAs commonly tested for, such as those ... SSA, SSB, and Scl-70. The test is also ...
... Immuno Concepts manufactures slides that are compatible ... to decrease the number of pipetting steps ... sample dilutions on the slides. Ask Immuno ... and these slides. These slide formats are ...
... patented HEp-2 cell line that has been ... SS-A/Ro autoantibodies, without affecting the other ANA ... published worldwide on the HEp-2000 ANA substrate, ... when used in place of standard HEp-2 ...
... ENA assays can be used to ... antibodies, which are associated with various ... lupus erythematosus (Lupus), Sjgren's syndrome, mixed ... scleroderma, polymyositis, dermatomyositis, and Raynaud's phenomenon. ...
Medicine Products: